GNTA
Price
$4.00
Change
-$0.30 (-6.98%)
Updated
Jun 6 closing price
Capitalization
73.19M
ROQAF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
3.78M
Interact to see
Advertisement

GNTA vs ROQAF

Header iconGNTA vs ROQAF Comparison
Open Charts GNTA vs ROQAFBanner chart's image
Genenta Science SpA
Price$4.00
Change-$0.30 (-6.98%)
Volume$2.71K
Capitalization73.19M
Roquefort Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$600
Capitalization3.78M
GNTA vs ROQAF Comparison Chart
Loading...
View a ticker or compare two or three
VS
GNTA vs. ROQAF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and ROQAF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GNTA: $4.00 vs. ROQAF: $0.05)
Brand notoriety: GNTA and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 46% vs. ROQAF: 100%
Market capitalization -- GNTA: $73.19M vs. ROQAF: $3.78M
GNTA [@Biotechnology] is valued at $73.19M. ROQAF’s [@Biotechnology] market capitalization is $3.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • GNTA’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, GNTA is a better buy in the long-term than ROQAF.

Price Growth

GNTA (@Biotechnology) experienced а -11.07% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GNTA is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
GNTA($73.2M) has a higher market cap than ROQAF($3.78M). ROQAF YTD gains are higher at: 0.000 vs. GNTA (-8.002).
GNTAROQAFGNTA / ROQAF
Capitalization73.2M3.78M1,937%
EBITDAN/AN/A-
Gain YTD-8.0020.000-
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMGX35.39N/A
N/A
Harding Loevner Global Equity Advisor
TILPX28.79N/A
N/A
Nuveen Large Cap Growth Premier
BMISX6.94N/A
N/A
BNY Mellon Income Stock C
FERRX11.46N/A
N/A
First Eagle Global Real Assets R6
IINCX24.42-0.05
-0.20%
Macquarie International Core Eq R6

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
-6.93%
CRBP - ROQAF
22%
Poorly correlated
+4.89%
SVRA - ROQAF
21%
Poorly correlated
+2.52%
SKYE - ROQAF
21%
Poorly correlated
+13.02%
SNTI - ROQAF
6%
Poorly correlated
+7.87%
More